These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12197333)

  • 21. [Endemic leprosy in the People's Republic of Congo. An epidemiological and behavioral analysis].
    Louis JP; Trebucq A; Hengy C; Coddy-Zitsamele R; Eozenou P; Baya-Tsika N; Obvala D; Jannin J; Gelas H; Cottenot F
    Acta Leprol; 1990; 7(3):213-20. PubMed ID: 2099584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.
    Courtright P; Daniel E; Sundarrao ; Ravanes J; Mengistu F; Belachew M; Celloria RV; Ffytche T
    Lepr Rev; 2002 Sep; 73(3):225-38. PubMed ID: 12449887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Leprosy situation in the southeastern region of Madagascar from 1996 to 1998].
    Razafimalala FC; Rakotomanga S; Rakotondramarina DB; Rakotomalala JN
    Acta Leprol; 2000-2001; 12(1):7-10. PubMed ID: 11526641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of mental distress in the outpatient clinic of a specialized leprosy hospital. Addis Ababa, Ethiopia, 2002.
    Leekassa R; Bizuneh E; Alem A
    Lepr Rev; 2004 Dec; 75(4):367-75. PubMed ID: 15682974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effect of leprosy control in two Prefectures of China, 1955-1993.
    Li HY; Weng XM; Li T; Zheng DY; Mao ZM; Ran SP; Liu FW
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):213-21. PubMed ID: 7602216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological trends of leprosy elimination in CLTRI rural field operation area, Tamil Nadu, India.
    Subramanian M; Thorat DM; Krishnan CB; Baig AA; Prabakaran I; Hassan TF; Oommen PK
    Indian J Lepr; 2006; 78(2):203-14. PubMed ID: 16927854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leprosy in Lome, Togo: retrospective study of 383 cases].
    Saka B; Kombate K; Mouhari-Toure A; Amegan-Aho KH; Tchangai-Walla K; Pitche P
    Med Trop (Mars); 2008 Oct; 68(5):496-8. PubMed ID: 19068982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign tumours of orofacial region at Benghazi, Libya: a study of 405 cases.
    El-Gehani R; Orafi M; Elarbi M; Subhashraj K
    J Craniomaxillofac Surg; 2009 Oct; 37(7):370-5. PubMed ID: 19362008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrafamilial transmission of leprosy in Vellore Town, India.
    George R; Rao PS; Mathai R; Jacob M
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):550-5. PubMed ID: 8151185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
    Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
    Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status.
    Sehgal VN; Sardana K; Dogra S
    J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairments in multibacillary leprosy; a study from Brazil.
    Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
    Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress towards the elimination of leprosy in Nigeria: a review of the role of policy implementation and operational factors.
    Ogbeiwi OI
    Lepr Rev; 2005 Mar; 76(1):65-76. PubMed ID: 15881037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
    Richardus JH; Habbema JD
    Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
    Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
    Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 20-year study of the Leprosy Control Programme at the Hemerijckx Leprosy Centre in Polambakkam in South India.
    Nair NG; Radhakrishna S; Christian M; Ramakrishnan R; Gopi PG
    Indian J Lepr; 1985; 57(3):562-74. PubMed ID: 3831094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of leprosy in Agra District (U.P.) India from 2001 to 20031.
    Kumar A; Girdhar A; Girdhar BK
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):115-21. PubMed ID: 16830654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of leprosy in urban Agra.
    Kumar A; Girdhar A; Girdhar BK
    Lepr Rev; 2003 Mar; 74(1):31-4. PubMed ID: 12669930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.